Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;373(5):376-80.
doi: 10.1007/s00210-006-0076-z. Epub 2006 May 31.

Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats

Affiliations

Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats

Aly M Abdelrahman et al. Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug.

Abstract

We investigated the effect of intermedin/adrenomedullin-2 (3 and 10 nmol/kg, i.v.), a member of the calcitonin gene-related peptide family, relative to the vehicle (0.9% NaCl) on mean circulatory filling pressure (index of venous tone) in conscious rats: intact (unblocked) or ganglionic blocked through treatment with mecamylamine (10 mg/kg, i.v.) and noradrenaline (4 microg/kg/min, i.v.). In intact rats, both doses of intermedin/adrenomedullin-2 reduced mean arterial pressure (-14+/-3, -30+/-3 mmHg), but did not alter mean circulatory filling pressure; the high dose also increased heart rate. In ganglionic-blocked rats, both doses decreased mean arterial pressure (-22+/-3, -46+/-5 mmHg) and the high dose also decreased mean circulatory filling pressure (-2.81+/-0.82 mmHg), but neither dose affected heart rate. The vehicle did not have any effects in any of the groups. In addition, intermedin/adrenomedullin-2 did not have any effect on blood volume in both intact and ganglion-blocked rats. The results show that intermedin/adrenomedullin-2 is a dilator of arterial resistance and capacitance vessels.

PubMed Disclaimer

References

    1. Trends Pharmacol Sci. 2000 Nov;21(11):432-8 - PubMed
    1. Eur J Pharmacol. 2005 Mar 7;510(1-2):107-11 - PubMed
    1. Eur J Pharmacol. 2003 Jun 6;470(3):171-5 - PubMed
    1. J Pharmacol Toxicol Methods. 2000 Sep-Oct;44(2):341-60 - PubMed
    1. Eur J Pharmacol. 1989 Mar 21;162(2):337-44 - PubMed

Publication types

MeSH terms

LinkOut - more resources